These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

570 related articles for article (PubMed ID: 12864754)

  • 1. Migraine prevalence and treatment patterns: the global Migraine and Zolmitriptan Evaluation survey.
    MacGregor EA; Brandes J; Eikermann A
    Headache; 2003 Jan; 43(1):19-26. PubMed ID: 12864754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of migraine on patients and their families: the Migraine And Zolmitriptan Evaluation (MAZE) survey--Phase III.
    MacGregor EA; Brandes J; Eikermann A; Giammarco R
    Curr Med Res Opin; 2004 Jul; 20(7):1143-50. PubMed ID: 15265259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Migraine treatment strategies: the global Migraine And Zolmitriptan Evaluation (MAZE) survey--phase IV.
    MacGregor EA; Brandes J; Gendolla A; Giammarco R
    Curr Med Res Opin; 2004 Nov; 20(11):1777-83. PubMed ID: 15537478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global trends in migraine care: results from the MAZE survey.
    Brandes JL
    CNS Drugs; 2002; 16 Suppl 1():13-8. PubMed ID: 12196035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and tolerability of zolmitriptan oral tablet in the acute treatment of menstrual migraine.
    Tuchman M; Hee A; Emeribe U; Silberstein S
    CNS Drugs; 2006; 20(12):1019-26. PubMed ID: 17140280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zolmitriptan orally disintegrating tablet is effective in the acute treatment of migraine.
    Dowson AJ; MacGregor EA; Purdy RA; Becker WJ; Green J; Levy SL
    Cephalalgia; 2002 Mar; 22(2):101-6. PubMed ID: 11972576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Newer formulations of the triptans: advances in migraine management.
    Gladstone JP; Gawel M
    Drugs; 2003; 63(21):2285-305. PubMed ID: 14524731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient preference for triptan formulations: a prospective study with zolmitriptan.
    Dowson A; Bundy M; Salt R; Kilminster S
    Headache; 2007 Sep; 47(8):1144-51. PubMed ID: 17883519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Speed of onset, efficacy and tolerability of zolmitriptan nasal spray in the acute treatment of migraine: a randomised, double-blind, placebo-controlled study.
    Dodick D; Brandes J; Elkind A; Mathew N; Rodichok L
    CNS Drugs; 2005; 19(2):125-36. PubMed ID: 15697326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute treatment of migraine with zolmitriptan 5 mg orally disintegrating tablet.
    Spierings EL; Rapoport AM; Dodick DW; Charlesworth B
    CNS Drugs; 2004; 18(15):1133-41. PubMed ID: 15581383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Zolmitriptan as fast-melt tablet in the acute treatment of patients with migraine attacks: the ZORO study].
    Stöckli HR; Sword A
    Praxis (Bern 1994); 2003 Feb; 92(9):379-89. PubMed ID: 12674591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review of zolmitriptan and its clinical applications in migraine.
    Dowson AJ; Charlesworth B
    Expert Opin Pharmacother; 2002 Jul; 3(7):993-1005. PubMed ID: 12083998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Speed of onset and efficacy of zolmitriptan nasal spray in the acute treatment of migraine: a randomised, double-blind, placebo-controlled, dose-ranging study versus zolmitriptan tablet.
    Charlesworth BR; Dowson AJ; Purdy A; Becker WJ; Boes-Hansen S; Färkkilä M
    CNS Drugs; 2003; 17(9):653-67. PubMed ID: 12828501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pain-free rates with zolmitriptan 2.5 mg ODT in the acute treatment of migraine: results of a large double-blind placebo- controlled trial.
    Loder E; Freitag FG; Adelman J; Pearlmand S; Abu-Shakra S
    Curr Med Res Opin; 2005 Mar; 21(3):381-9. PubMed ID: 15811207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An open preference study with sumatriptan 50 mg and zolmitriptan 2.5 mg in 100 migraine patients.
    Pascual J; Muñoz R; Leira R
    Cephalalgia; 2001 Jul; 21(6):680-4. PubMed ID: 11531900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tolerability and consistency of effect of zolmitriptan nasal spray in a long-term migraine treatment trial.
    Dowson AJ; Charlesworth BR; Purdy A; Becker WJ; Boes-Hansen S; Färkkilä M
    CNS Drugs; 2003; 17(11):839-51. PubMed ID: 12921494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and tolerability of oral zolmitriptan in menstrually associated migraine: a randomized, prospective, parallel-group, double-blind, placebo-controlled study.
    Loder E; Silberstein SD; Abu-Shakra S; Mueller L; Smith T
    Headache; 2004 Feb; 44(2):120-30. PubMed ID: 14756849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patients with migraine prefer zolmitriptan orally disintegrating tablet to sumatriptan conventional oral tablet.
    Dowson AJ; Charlesworth BR
    Int J Clin Pract; 2003 Sep; 57(7):573-6. PubMed ID: 14529055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zolmitriptan versus a combination of acetylsalicylic acid and metoclopramide in the acute oral treatment of migraine: a double-blind, randomised, three-attack study.
    Geraud G; Compagnon A; Rossi A;
    Eur Neurol; 2002; 47(2):88-98. PubMed ID: 11844897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Part III: the convenience of, and patient preference for, zolmitriptan orally disintegrating tablet.
    Dowson AJ; Almqvist P
    Curr Med Res Opin; 2005; 21 Suppl 3():S13-7. PubMed ID: 16083519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.